サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363144

クリティカルケア診断の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency Rooms, Intensive Care Units), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 85 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
クリティカルケア診断の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月22日
発行: Grand View Research
ページ情報: 英文 85 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

クリティカルケア診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、クリティカルケア診断の世界市場規模は2030年までに17億2,000万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 4.9％で成長すると予測されます。この業界の成長を支える主な要因は、医師や患者によるこれらの検査に対する認識と認知の急速な高まり、高齢者人口と慢性的な健康状態の増加、遠隔地における遠隔医療サービスの採用、技術の進歩です。分子診断のコスト上昇と熟練労働者の不足は、業界の成長を阻害する要因であると予想されます。

クリティカルケア診断市場をタイプ別に分類すると、ルーチン化学、特殊化学、フローサイトメトリー、血液学、免疫タンパク質、微生物・感染症、凝固検査、その他に分類されます。微生物・感染症検査診断セグメントは、予測期間中のCAGRが5.5%を超え、最も高い成長率が予測されています。例えば、ヘルスケアシステムは病原体の同定のために血液培養の収集と処理にかなりのリソースを費やしています。

核酸増幅検査のようなクリティカルケア診断検査は、臨床医がより迅速かつ正確に細菌を検出・同定することを可能にし、適切な抗菌薬治療を可能な限り迅速に開始し、回避可能な薬剤の使用を中止することを望む臨床医に指針を提供します。最終用途別のクリティカルケア診断市場は、手術室、救急室、ICUに分類されます。予測期間中、最も高い成長率が見込まれるのは救急室分野です。

クリティカルケア診断市場レポートハイライト

  • アジア太平洋地域は予測期間中にCAGR 6.9%で最速の成長が見込まれます。高齢者人口の多さ、慢性疾患の有病率の増加、アジア太平洋地域における専門病院数の増加、農村部におけるヘルスケアサービスとインフラの改善が市場成長を促進する要因です。
  • クリティカルケア診断市場のタイプ別シェアでは、免疫タンパク質診断検査分野が最大を占めると推定されます。迅速かつ正確な予防ヘルスケアサービスに対する需要の高まりが、この市場成長を促進する主な要因の1つです。
  • 最終用途別では、急性期医療患者の約20％がICUに入院しているのに対し、約58％が救急治療室に入院しています。救急治療室は、予測期間中に最も高いCAGRで飛躍的な成長が見込まれています。ERサービスに対する患者需要の最近の高まりは、初期急性期治療の診断と重症患者の治療を提供するERの能力によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 クリティカルケア診断市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • クリティカルケア診断市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 クリティカルケア診断：タイプの推定・動向分析

  • クリティカルケア診断市場：重要なポイント
  • クリティカルケア診断市場：動向と市場シェア分析、2022年および2030年
  • ルーチンおよび特殊化学
  • フローサイトメトリー
  • 血液学
  • 免疫タンパク質
  • 微生物と感染症
  • 凝固検査
  • その他

第5章 クリティカルケア診断：最終用途別推定・動向分析

  • クリティカルケア診断市場：重要なポイント
  • クリティカルケア診断市場：動向と市場シェア分析、2022年と2030年
  • 手術室
  • 集中治療室
  • 緊急治療室
  • その他

第6章 クリティカルケア診断市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別のクリティカルケア診断市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Abbott
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • BD
    • EKF Diagnostics
    • bioMerieux, Inc.
    • Siemens Healthcare Private Limited
    • Chembio Diagnostics, Inc.
    • Bayer AG
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 17 France critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Japan critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 India critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait critical care diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Critical care diagnostics: Market outlook
  • Fig. 8 Critical care diagnostics: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Critical care diagnostics market driver impact
  • Fig. 14 Critical care diagnostics market restraint impact
  • Fig. 15 Critical care diagnostics market strategic initiatives analysis
  • Fig. 16 Critical care diagnostics market: Type movement analysis
  • Fig. 17 Critical care diagnostics market: Type outlook and key takeaways
  • Fig. 18 Routine and special chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Immunoproteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Microbial and infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Coagulation testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Critical care diagnostics market: End use movement analysis
  • Fig. 26 Critical care diagnostics market: End use outlook and key takeaways
  • Fig. 27 Operation room market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Intensive care unit market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Emergency rooms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global critical care diagnostics market: Regional movement analysis
  • Fig. 32 Global critical care diagnostics market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-010-1

Critical Care Diagnostics Market Growth & Trends:

The global critical care diagnostics market size is expected to reach USD 1.72 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 4.9% from 2023 to 2030. The key factors supporting the industry's growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 5.5% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU's. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Critical Care Diagnostics Market Report Highlights:

  • The Asia Pacific region is expected to grow at the fastest CAGR of 6.9% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.
  • The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.
  • On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU's, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Critical Care Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Critical Care Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Critical Care Diagnostics: Type Estimates & Trend Analysis

  • 4.1. Critical Care Diagnostics Market: Key Takeaways
  • 4.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Routine and Special Chemistry
    • 4.3.1. Routine and special chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Flow Cytometry
    • 4.4.1. Flow cytometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Hematology
    • 4.5.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Immunoproteins
    • 4.6.1. Immunoproteins market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Microbial and Infectious Disease
    • 4.7.1. Microbial and infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Coagulation Testing
    • 4.8.1. Coagulation testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Critical Care Diagnostics: End Use Estimates & Trend Analysis

  • 5.1. Critical Care Diagnostics Market: Key Takeaways
  • 5.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Operation Room
    • 5.3.1. Operation room market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Intensive Care Unit
    • 5.4.1. Intensive care unit market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Emergency Rooms
    • 5.5.1. Emergency rooms market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Critical Care Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Critical Care Diagnostics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Danaher
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. F. Hoffmann-La Roche Ltd
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. BD
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. EKF Diagnostics
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. bioMerieux, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Siemens Healthcare Private Limited
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Chembio Diagnostics, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Bayer AG
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives